Skip to content
healthcare.dev

terazosin

NDC 53401-022, terazosin, capsule, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
53401-022
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075614
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/53401-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE1 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
53401-022-535340100225360 CAPSULE in 1 BOTTLE (53401-022-53)
53401-022-605340100226090 CAPSULE in 1 BOTTLE (53401-022-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/57125b47-2156-181c-e063-6394a90ad763

Use it

Look up 53401-022 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/53401-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 53401-022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.